You are here

Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
New Haven, Connecticut, 06511-5473 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Respiratory Tract Infections
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Volunteers willing and able to be confined to the Clinical Research Unit and comply
with study schedule.

- Women of non-childbearing potential only.

- Japanese subjects muct have 4 Japanese grandparents who were born in Japan.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Previous antibiotic use within 14 days prior to dosing.

- Use of antibiotics during hospitalization within 90 days prior to dosing.

- History of sensitivity to macrolides or ketolides.

- Presence of clinically significant eye conditions (other than corrective lenses).

NCT00793000
Pfizer
Completed
Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Respiratory Tract Infections
NCT03529773
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now